Tag Archives: Potential Inaccurate Dosage Delivery

DIOXIDO DE CLORO| uso en Bolivia para tratar la COVID-19

El uso del dióxido de cloro, una sustancia utilizada para desinfectar, como supuesta alternativa contra la COVID-19 ha generado en Bolivia una polémica hasta el punto de que las autoridades advierten de procesos penales por sus riesgos para la salud.

Es muy facil de ver la mentira cuando intenta descalificar al dioxido de cloro.

La Médica Científica, Patricia Callisperis, quien demostró resultados exitosos en el Beni tratando pacientes Covid 19 con el suministro del Dióxido de Cloro, propone el uso de un protocolo que puede ser aplicado de manera preventiva en el Departamento, con el fin de que pacientes ya no necesiten un respirador artificial,según afirmó la entrevistada.

Fair Use Notice: Images/logos/graphics on this page contains some copyrighted material whose use has not been authorized by the copyright owners. We believe that this not-for-profit, educational, and/or criticism or commentary use on the Web constitutes a fair use of the copyrighted material (as provided for in section 107 of the US Copyright Law).

Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery

Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q® Due to Potential Inaccurate Dosage Delivery
10/28/2015 09:38 PM EDT

Sanofi US is voluntarily recalling all Auvi-Q (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for hospitals, retailers and consumers. This includes lot number 2299596 through 3037230, which expire March 2016 through December 2016. The products have been found to potentially have inaccurate dosage delivery.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.